LFMD Logo

LifeMD, Inc. (LFMD) 

NASDAQ
Market Cap
$244.71M
Sector
Healthcare
Industry
Medical—Pharmaceuticals
Rank in Sector
301 of 774
Rank in Industry
3 of 6

Largest Insider Buys in Sector

LFMD Stock Price History Chart

LFMD Stock Performance

About LifeMD, Inc.

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men's sexual health, dermatology, and others in the United States. The company provides ShapiroMD, a telehealth platform brand that offers access to virtual medical treatment, prescription medications, patented-doctor formulated OTC products, and an FDA approved medical device for male and female hair loss, and female specific topical compounded medications for hair …

Insider Activity of LifeMD, Inc.

Over the last 12 months, insiders at LifeMD, Inc. have bought $14,790 and sold $0 worth of LifeMD, Inc. stock.

On average, over the past 5 years, insiders at LifeMD, Inc. have bought $873,248 and sold $401,000 worth of stock each year.

Highest buying activity among insiders over the last 12 months: Galluppi Stefan (Chief Innovation Officer) — $14,790.

The last purchase of 3,000 shares for transaction amount of $14,790 was made by Galluppi Stefan (Chief Innovation Officer) on 2024‑09‑11.

List of Insider Buy and Sell Transactions, LifeMD, Inc.

2024-09-11PurchaseChief Innovation Officer
3,000
0.0069%
$4.93$14,790+6.09%
2023-08-31Purchasedirector
60,000
0.1695%
$3.93$235,800+84.46%
2023-08-30Purchasedirector
40,000
0.1084%
$3.76$150,400+83.85%
2023-08-29Purchasedirector
32,072
0.0871%
$3.58$114,818+93.34%
2023-06-14Purchasedirector
3,945
0.0123%
$2.94$11,580+127.52%
2023-06-14PurchaseChief Acquisition Officer
10,712
0.0331%
$2.92$31,279+127.52%
2023-06-13Purchasedirector
49,465
0.1422%
$2.64$130,375+133.45%
2023-06-13PurchaseGeneral Counsel & CCO
11,500
0.0326%
$2.60$29,900+133.45%
2023-06-07Purchasedirector
24,500
0.0768%
$2.19$53,547+204.55%
2023-06-06Purchasedirector
129,117
0.4074%
$2.18$281,398+205.96%
2023-06-05Purchasedirector
10,383
0.0325%
$2.17$22,480+205.96%
2023-05-26PurchaseChief Operating Officer
30,000
0.0951%
$2.19$65,706+194.04%
2023-05-23PurchaseCEO
32,336
0.0992%
$2.06$66,612+200.94%
2023-05-23PurchaseChief Innovation Officer
4,608
0.0149%
$2.17$9,999+200.94%
2023-05-22PurchaseCEO
17,664
0.0555%
$2.15$38,013+193.98%
2022-05-18Purchase
50,000
0.1628%
$2.14$106,800-2.82%
2022-03-14PurchaseGeneral Counsel & CCO
5,000
0.0165%
$3.14$15,700-29.45%
2022-03-10Purchase
2,000
0.0062%
$3.28$6,560-36.15%
2021-12-07Purchasedirector
25,000
0.0931%
$4.54$113,500-44.86%
2021-12-03Purchasedirector
110,000
0.406%
$3.91$430,100-36.27%

Insider Historical Profitability

37.08%
Galluppi StefanChief Innovation Officer
45449
0.1049%
$5.6561+14.28%
Schreiber JustinCEO
2844620
6.5677%
$5.65280+85.91%
Walters Happy David
2148956
4.9616%
$5.65140+31.27%
Velge Bertranddirector
349482
0.8069%
$5.65120+129.24%
BHATIA NAVEEN
246349
0.5688%
$5.6530<0.0001%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Divisadero Street Capital Management Lp$17.41M41.69M-8.31%-$1.58M4.09
Invesco$11.98M2.761.17M+36.93%+$3.23M<0.01
The Vanguard Group$11.88M2.731.16M+12.54%+$1.32M<0.0001
ROYCE & ASSOCIATES INC$8.24M1.9801,595-3.73%-$318,998.700.07
Connor Clark & Lunn Investment Management Ltd$6.13M1.41595,907+292.97%+$4.57M0.01
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.